Quantcast

Latest Haloperidol Stories

2012-05-08 10:57:02

Biological Psychiatry article provides insights from animal studies It is increasingly recognized that chronic psychotropic drug treatment may lead to structural remodeling of the brain. Indeed, clinical studies in humans present an intriguing picture: antipsychotics, used for the treatment of schizophrenia and psychosis, may contribute to cortical gray matter loss in patients, whereas lithium, used for the treatment of bipolar disorder and mania, may preserve gray matter in patients....

2012-03-02 05:53:58

(Ivanhoe Newswire)-- Elderly folks ages 65 and up who are living in a nursing home and taking certain antipsychotic medications for dementia could be hastening their death. The Harvard Medical School undertook the largest study ever among US nursing home residents, researchers looked at 75,445 older nursing home residents from 45 US states between 2001 and 2005. All nursing home residents studied were at least 65 years of age. Risks of mortality were examined over a 6 months period. The...

Antipsychotic Medication Death Rate Among Dementia Patients Analyzed
2012-02-27 06:21:22

A new Harvard Medical School (HMS) and Brigham and Women's Hospital study has discovered that some types of antipsychotic medication present more of a risk of death in older dementia patients than others. According to MedPage Today North American Correspondent Michael Smith, Dr. Krista Huybrechts of the Boston hospital and colleagues looked at six medications used to treat dementia in more than 75,000 nursing home residents over the age of 65 who had started using the drugs between 2001...

2012-02-23 18:00:25

Research: Differential risk of death in older nursing home residents prescribed specific antipsychotic medications: Population-based cohort study Nursing home residents over the age of 65 who take certain antipsychotic medication for dementia are at an increased risk of death, suggests a research paper published today on bmj.com. The Harvard Medical School study, the largest ever undertaken among US nursing home residents, looked at 75,445 older nursing home residents from 45 US states...

2011-04-07 07:00:00

FLORHAM PARK, N.J., April 7, 2011 /PRNewswire/ -- Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. commercial availability of CUVPOSA(TM) (glycopyrrolate) oral solution, the first and only FDA-approved treatment to reduce chronic severe drooling in patients aged 3 to 16 with neurologic conditions associated with problem drooling, such as cerebral palsy. "Shionogi is proud to expand its mission of helping to bring high quality care to...

76fc78a0fa0ee5f933feaa03bdf098f81
2010-06-27 13:29:48

A new study shows that use of psychotropic medications during pregnancy increase the probability of birth defects. Researchers at the University of Copenhagen have published an article that documents the serious side effects that can be associated with these types of medications. Between 1998 and 2007, psychotropic medications were associated with 429 adverse drug reactions in Danish children under the age of 17. Researchers from the University of Copenhagen's Faculty of Pharmaceutical...

2010-06-23 14:12:20

Between 1998 and 2007, psychotropic medications were associated with 429 adverse drug reactions (ADRs) in children under 17 in Denmark. Researchers writing in the open access journal BMC Research Notes found that more than half of these were serious and several were birth defects "“ suggesting that tighter controls on the prescription of psychotropic medications to pregnant women may be required. Lise Aagaard and Ebba Holme Hansen from the University of Copenhagen, Denmark, studied all...

2010-06-04 00:23:00

EAST HANOVER, N.J., June 4 /PRNewswire/ -- Novartis announced today 18-month results (median follow-up) showing that Tasigna® (nilotinib) capsules significantly surpass the efficacy of Gleevec® (imatinib mesylate) tablets* in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase(1). To view the multimedia assets associated with this release, please click:...

2010-02-19 00:32:00

EAST HANOVER, N.J., Feb. 19 /PRNewswire/ -- Novartis announced today that Tasigna® (nilotinib) 200 mg capsules has been granted priority review by the US Food and Drug Administration (FDA) for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. FDA priority review status is granted to therapies that offer major advances in treatment or provide a treatment where no adequate therapy...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'